| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00406-009-0868-5 |
| P698 | PubMed publication ID | 19224107 |
| P50 | author | Georg Juckel | Q28868886 |
| P2093 | author name string | Patrik Roser | |
| Jürgen Gallinat | |||
| Andreas M Stadelmann | |||
| Inge Gorynia | |||
| Gordon Weinberg | |||
| P2860 | cites work | Cannabinoid receptor localization in brain | Q24558751 |
| The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin | Q24643876 | ||
| The orphan receptor GPR55 is a novel cannabinoid receptor | Q24670137 | ||
| The assessment and analysis of handedness: The Edinburgh inventory | Q26778476 | ||
| Structure of a cannabinoid receptor and functional expression of the cloned cDNA | Q28240076 | ||
| Cannabis and schizophrenia. A longitudinal study of Swedish conscripts | Q28283322 | ||
| Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide | Q28362078 | ||
| Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata | Q28377147 | ||
| Specific imbalance of right and left sided motor neuron excitability in schizophrenia | Q33631059 | ||
| Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controls | Q33682548 | ||
| Motor actions of cannabinoids in the basal ganglia output nuclei | Q33720160 | ||
| Meta-analysis of corpus callosum size in schizophrenia | Q33733969 | ||
| Psychiatric effects of cannabis | Q33931259 | ||
| Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists | Q34103173 | ||
| Cannabidiol: an overview of some pharmacological aspects | Q34157378 | ||
| Cannabis and the brain | Q34199483 | ||
| The role of the corpus callosum in interhemispheric transfer of information: excitation or inhibition? | Q36279952 | ||
| Cannabinoids | Q36304872 | ||
| Cannabinoids and psychosis | Q36756388 | ||
| Neurophysiological mechanisms of psychotic symptoms. | Q37317886 | ||
| Impact of substance abuse on the course and outcome of schizophrenia | Q37920159 | ||
| Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia | Q38401669 | ||
| Schizophrenia: a disease of interhemispheric processes at forebrain and brainstem levels? | Q38677415 | ||
| Cognitive and sensori-motor functioning in the absence of the corpus callosum: neuropsychological studies in callosal agenesis and callosotomized patients | Q40582212 | ||
| Persistent topographic quantitative EEG sequelae of chronic marihuana use: a replication study and initial discriminant function analysis | Q41036877 | ||
| Hemispheric asymmetries and schizophrenia: a preliminary magnetic resonance imaging study. | Q41349416 | ||
| Characterization of cytochrome P450 3A inactivation by cannabidiol: possible involvement of cannabidiol-hydroxyquinone as a P450 inactivator | Q42538925 | ||
| Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. | Q43581230 | ||
| Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. | Q43641975 | ||
| Functional motor asymmetries correlated with clinical findings in unmedicated schizophrenic patients | Q43739616 | ||
| Regional cortical dysfunction in schizophrenic patients studied by computerized neuropsychological methods | Q43875309 | ||
| Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia | Q44748286 | ||
| Role of the endogenous cannabinoid system as a modulator of dopamine transmission: implications for Parkinson's disease and schizophrenia | Q44865127 | ||
| Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers | Q46547451 | ||
| Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract | Q46819181 | ||
| Acute effects of Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity | Q46989796 | ||
| Role of the endogenous cannabinoid system in the regulation of motor activity | Q48285177 | ||
| Presynaptic inhibition of GABAergic inputs to rat substantia nigra pars reticulata neurones by a cannabinoid agonist | Q48484213 | ||
| A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis. | Q49029597 | ||
| Caudate, putamen, and globus pallidus volume in schizophrenia: a quantitative MRI study. | Q51017596 | ||
| Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects. | Q52210240 | ||
| Developmental arrest of cerebral asymmetries in early onset schizophrenia. | Q52245170 | ||
| Intermanual coordination in relation to different clinical subgroups in right-handed patients with schizophrenic and other psychotic disorders. | Q52952337 | ||
| Instability in functional motor laterality of children and adolescents with endogenous psychosis and predominantly motor disturbances. | Q53019663 | ||
| A Total Synthesis of dl-Δ1-Tetrahydrocannabinol, the Active Constituent of Hashish1 | Q55970558 | ||
| Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system. | Q64996366 | ||
| The finger-tapping test. A quantitative analysis | Q68800087 | ||
| Psychomotor disturbances in psychiatric patients as a possible basis for new attempts at differential diagnosis and therapy. II. Cross validation study on schizophrenic patients: persistence of a "psychotic motor syndrome" as possible evidence of an | Q69568429 | ||
| Neurological abnormalities in schizophrenic patients | Q71207065 | ||
| EEG coherence, lateral preference and schizophrenia | Q71808621 | ||
| Fine motor performance before and after treatment in schizophrenic and schizoaffective patients | Q72028914 | ||
| Cannabis consumption as a prognostic factor in schizophrenia | Q72706301 | ||
| Elevated endogenous cannabinoids in schizophrenia | Q73029596 | ||
| Topographic quantitative EEG sequelae of chronic marihuana use: a replication using medically and psychiatrically screened normal subjects | Q73100890 | ||
| The effects of hand preference and gender on finger tapping performance asymmetry by the use of an infra-red light measurement device | Q73479965 | ||
| Intermanual coordination in relation to handedness, familial sinistrality and lateral preferences | Q73574741 | ||
| Activational role of cannabinoids on movement | Q73575705 | ||
| Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia | Q78254908 | ||
| P433 | issue | 5 | |
| P921 | main subject | tetrahydrocannabinol | Q190067 |
| cannabinoids | Q422936 | ||
| human subject research project | Q1331083 | ||
| P304 | page(s) | 284-292 | |
| P577 | publication date | 2009-02-17 | |
| P1433 | published in | European Archives of Psychiatry and Clinical Neuroscience | Q661388 |
| P1476 | title | Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects | |
| P478 | volume | 259 |
| Q51731195 | A Novel Observational Method for Assessing Acute Responses to Cannabis: Preliminary Validation Using Legal Market Strains. |
| Q35740630 | Altered brain activation during visuomotor integration in chronic active cannabis users: relationship to cortisol levels |
| Q27005619 | Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review |
| Q34657897 | Cannabidiol in humans-the quest for therapeutic targets |
| Q90245078 | Cannabis Use: Neurobiological, Behavioral, and Sex/Gender Considerations |
| Q36177321 | Cortico-cerebellar abnormalities in adolescents with heavy marijuana use |
| Q89329527 | Delta-9-tetrahydrocannabinol and cannabidiol: Separating the chemicals from the "weed," a pharmacodynamic discussion |
| Q37054169 | Effects of Cannabis sativa extract on haloperidol-induced catalepsy and oxidative stress in the mice |
| Q36672926 | Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences |
| Q56453283 | Identification and quantification of cannabinoids in Cannabis sativa L. plants by high performance liquid chromatography-mass spectrometry |
| Q33901507 | Neurological soft signs in Tunisian patients with first-episode psychosis and relation with cannabis use |
| Q37006281 | Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis |
| Q26741475 | Sex Effects of Marijuana on Brain Structure and Function |
Search more.